Adage Capital Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,000
| Closed | -$3.32M | – | 864 |
|
|
2024
Q4 | $3.32M | Buy |
65,000
+25,000
| +63% | +$1.28M | 0.01% | 753 |
|
|
2024
Q3 | $2.04M | Sell |
40,000
-161,048
| -80% | -$8.23M | ﹤0.01% | 782 |
|
|
2024
Q2 | $9M | Sell |
201,048
-431,085
| -68% | -$19.3M | 0.02% | 623 |
|
|
2024
Q1 | $29.6M | Buy |
+632,133
| New | +$29.6M | 0.06% | 359 |
|
|
2023
Q3 | – | Sell |
-225,000
| Closed | -$4.05M | – | 881 |
|
|
2023
Q2 | $4.05M | Buy |
+225,000
| New | +$4.05M | 0.01% | 690 |
|
|
2019
Q3 | – | Sell |
-490,000
| Closed | -$12.3M | – | 725 |
|
|
2019
Q2 | $12.3M | Buy |
490,000
+200,000
| +69% | +$5M | 0.03% | 493 |
|
|
2019
Q1 | $6.6M | Hold |
290,000
| – | – | 0.02% | 581 |
|
|
2018
Q4 | $8.7M | Buy |
290,000
+90,000
| +45% | +$2.7M | 0.02% | 534 |
|
|
2018
Q3 | $5.73M | Buy |
+200,000
| New | +$5.73M | 0.01% | 624 |
|